Search Results 641-650 of 17535 for driving with dementia
Research. Researchers at Mayo Clinic study Alzheimer's disease, mild cognitive impairment, and other conditions that affect memory and thinking skills.
Memantine and donepezil combination is used to treat dementia (memory loss and mental changes) associated with moderate or severe Alzheimer's disease.
One of the challenges in addressing Alzheimer's disease, dementia, cognitive impairment and aging is not related to the conditions themselves but rather the ...
As a member of the Aging and Dementia Imaging Research Laboratory and multidisciplinary clinical research teams, she studies dementia ... Reviewer, Alzheimer's ...
Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are not alert, well- ...
Watch Mayo Clinic neurologist Ronald C. Petersen, M.D., Ph.D., talk about mild cognitive impairment on HBO — The Alzheimer's Project. Research Profiles. Edit ...
The purpose of this study is the validation of biomarker measures and to nform clinical trial design. Participation eligibility. Participant eligibility ...
... dementia. Aducanumab targets amyloid plaques in the brain that are believed to be an essential component of Alzheimer's disease. But what does the approval ...
Typical Alzheimer's disease is when it starts after age 65.” Charlie Leonard. “And it would interfere with some little parts of her job, particularly toward the.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.